These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22056566)

  • 21. [Iron replacement. Oral or parenteral?].
    Gattermann N
    Internist (Berl); 1998 May; 39(5):532-3. PubMed ID: 9647996
    [No Abstract]   [Full Text] [Related]  

  • 22. [Iron deficiency anemia and use of intravenous iron in digestive disease].
    Mearin F; Balboa A; Castells A; Domínguez JE; Esteve M; García-Erce JA; Gisbert JP; Gomollón F; Panés J; Ponce J
    Gastroenterol Hepatol; 2010 Oct; 33(8):605-13. PubMed ID: 20850906
    [No Abstract]   [Full Text] [Related]  

  • 23. Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial.
    Al RA; Unlubilgin E; Kandemir O; Yalvac S; Cakir L; Haberal A
    Obstet Gynecol; 2005 Dec; 106(6):1335-40. PubMed ID: 16319260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: a randomized, placebo-controlled study.
    Crosby L; Palarski VA; Cottington E; Cmolik B
    Heart Lung; 1994; 23(6):493-9. PubMed ID: 7852064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulating erythropoiesis in inflammatory bowel disease associated anemia.
    Tsiolakidou G; Koutroubakis IE
    World J Gastroenterol; 2007 Sep; 13(36):4798-806. PubMed ID: 17828809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parenteral iron supplementation for the treatment of iron deficiency anemia in children.
    Surico G; Muggeo P; Muggeo V; Lucarelli A; Martucci T; Daniele M; Rigillo N
    Ann Hematol; 2002 Mar; 81(3):154-7. PubMed ID: 11904741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial.
    Auerbach M; Ballard H; Trout JR; McIlwain M; Ackerman A; Bahrain H; Balan S; Barker L; Rana J
    J Clin Oncol; 2004 Apr; 22(7):1301-7. PubMed ID: 15051778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Bonovas S; Fiorino G; Allocca M; Lytras T; Tsantes A; Peyrin-Biroulet L; Danese S
    Medicine (Baltimore); 2016 Jan; 95(2):e2308. PubMed ID: 26765407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research progress of anemia associated with inflammatory bowel diseases].
    Hong ZW; Ren JA
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jun; 15(6):644-7. PubMed ID: 22736141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infusion of total dose iron versus oral iron supplementation in ambulatory peritoneal dialysis patients: a prospective, cross-over trial.
    Ahsan N
    Adv Perit Dial; 2000; 16():80-4. PubMed ID: 11045266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised clinical trial: oral vs. intravenous iron after upper gastrointestinal haemorrhage--a placebo-controlled study.
    Bager P; Dahlerup JF
    Aliment Pharmacol Ther; 2014 Jan; 39(2):176-87. PubMed ID: 24251969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation.
    Mudge DW; Tan KS; Miles R; Johnson DW; Badve SV; Campbell SB; Isbel NM; van Eps CL; Hawley CM
    Transplantation; 2012 Apr; 93(8):822-6. PubMed ID: 22290270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing iron deficiency and iron deficiency anemia in inflammatory bowel disease. The results of the "Gestiona hierro-EII" survey.
    Casellas Jordá F; Vera Mendoza I; Barreiro-de Acosta M; Vázquez Morón JM; López Román J; Júdez Gutiérrez J
    Rev Esp Enferm Dig; 2018 Mar; 110(3):172-178. PubMed ID: 29465251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral iron supplementation with Feralgine® in inflammatory bowel disease: a retrospective observational study.
    Vernero M; Boano V; Ribaldone DG; Pellicano R; Astegiano M
    Minerva Gastroenterol Dietol; 2019 Sep; 65(3):200-203. PubMed ID: 30917629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishing maintenance doses of lV iron in anemia management to improve patient outcomes.
    Nguyen TV; Wells D
    Nephrol Nurs J; 2011; 38(1):55-8; quiz 59. PubMed ID: 21469554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intravenous iron for the treatment of anemia in a day hospital: between inflammation and bleeding].
    Méndez Bailón M; Muñoz Rivas N
    Gastroenterol Hepatol; 2010 Dec; 33(10):755-6. PubMed ID: 21051114
    [No Abstract]   [Full Text] [Related]  

  • 38. SAFETY AND EFFICACY OF INTRAVENOUS ADMINISTRATION OF IRON PREPARATIONS.
    Grzywacz A; Lubas A; Fiedor P; Fiedor M; Niemczyk S
    Acta Pol Pharm; 2017 Jan; 74(1):13-24. PubMed ID: 29474757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ITDI is the preferred treatment for iron supplementation in rHuEpo-treated anemic PD patients.
    Ahsan N
    Adv Perit Dial; 1998; 14():228-31. PubMed ID: 10649730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial.
    de Silva AD; Tsironi E; Feakins RM; Rampton DS
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1097-105. PubMed ID: 16305723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.